141 related articles for article (PubMed ID: 9619537)
1. Unilateral hydrothorax as a sole and recurrent manifestation of ovarian hyperstimulation syndrome following in-vitro fertilization.
Friedler S; Rachstein A; Bukovsky I; Ron-El R; Raziel A
Hum Reprod; 1998 Apr; 13(4):859-61. PubMed ID: 9619537
[TBL] [Abstract][Full Text] [Related]
2. Severe unilateral hydrothorax as the only manifestation of the ovarian hyperstimulation syndrome.
Rabinerson D; Shalev J; Royburt M; Ben-Rafael Z; Dekel A
Gynecol Obstet Invest; 2000; 49(2):140-2. PubMed ID: 10671825
[TBL] [Abstract][Full Text] [Related]
3. A unilateral hydrothorax as the only manifestation of ovarian hyperstimulation syndrome: a case report.
Bassil S; Da Costa S; Toussaint-Demylle D; Lambert M; Gordts S; Donnez J
Fertil Steril; 1996 Dec; 66(6):1023-5. PubMed ID: 8941073
[TBL] [Abstract][Full Text] [Related]
4. Ovarian hyperstimulation syndrome manifests as acute unilateral hydrothorax.
Daniel Y; Yaron Y; Oren M; Peyser MR; Lessing JB
Hum Reprod; 1995 Jul; 10(7):1684-5. PubMed ID: 8582961
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Complexities in a Case of Ovarian Hyperstimulation Syndrome Presented Solely as a Unilateral Massive Hydrothorax.
Garzia E; Galiano V; Riparini J; Sulpizio P
Reprod Sci; 2021 Apr; 28(4):1026-1030. PubMed ID: 33469877
[TBL] [Abstract][Full Text] [Related]
6. Isolated severe hydrothorax with respiratory distress as a main manifestation of ovarian hyperstimulation syndrome preceded by respiratory tract infection caused by Haemophilus influenzae.
Ciepiela P; Brelik P; Baczkowski T; Kurzawa R
Ginekol Pol; 2007 Jul; 78(7):570-3. PubMed ID: 17915416
[TBL] [Abstract][Full Text] [Related]
7. Respiratory distress caused by a unilateral hydrothorax as only manifestation of ovarian hyperstimulation syndrome.
Qublan HS; Barakat M
J Obstet Gynaecol; 2006 Aug; 26(6):585-6. PubMed ID: 17000522
[No Abstract] [Full Text] [Related]
8. Massive unilateral hydrothorax as the only clinical manifestation of ovarian hyperstimulation syndrome.
Cordani S; Bancalari L; Maggiani R; La Sala GB; Fiasella F; Canessa PA
Monaldi Arch Chest Dis; 2002; 57(5-6):314-7. PubMed ID: 12814049
[TBL] [Abstract][Full Text] [Related]
9. Hydrothorax as the sole manifestation of ovarian hyperstimulation syndrome: unusual case and literature review.
Khairy M; El-Toukhy T; Emovon E; Khalaf Y
Reprod Biomed Online; 2007 Jun; 14(6):715-7. PubMed ID: 17579985
[TBL] [Abstract][Full Text] [Related]
10. [Unilateral pleural effusion in ovarian hyperstimulation syndrome].
Barile D; Bataille Y; Duysinx BC; Lambermont B; Louis R
Rev Med Liege; 2008; 63(7-8):474-9. PubMed ID: 18771225
[TBL] [Abstract][Full Text] [Related]
11. Hydrothorax following ovarian hyperstimulation for assisted reproduction. Case report and review of the literature.
Abbamonte LH; Remorgida V; Ferrero S; Ragni N; Anserini P
Minerva Ginecol; 2007 Feb; 59(1):85-90. PubMed ID: 17353877
[TBL] [Abstract][Full Text] [Related]
12. [Ovarian hyperstimulation syndrome with bilateral hydrothorax and ascites].
Jensen J; Merli F; Silingardi M; Aguzzoli F; Braglia D; Burani E; Iori I
Riv Eur Sci Med Farmacol; 1991; 13(5-6):223-5. PubMed ID: 1819849
[TBL] [Abstract][Full Text] [Related]
13. First case report of serous otitis media as a complication of severe ovarian hyperstimulation syndrome: Case report and literature review.
Santistevan L; Lonergan D; Eyvazzadeh AD
Int J Gynaecol Obstet; 2024 Mar; 164(3):843-847. PubMed ID: 37525483
[TBL] [Abstract][Full Text] [Related]
14. Isolated pleural effusion in severe ovarian hyperstimulation: A case report.
Gregory WT; Patton PE
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 1):1468-71. PubMed ID: 10368491
[TBL] [Abstract][Full Text] [Related]
15. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
Nardo LG; Cheema P; Gelbaya TA; Horne G; Fitzgerald CT; Pease EH; Brison DR; Lieberman BA
Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
[TBL] [Abstract][Full Text] [Related]
16. Severe ovarian hyperstimulation syndrome and combined intrauterine and tubal pregnancy after in-vitro fertilization and embryo transfer.
Moosburger D; Tews G
Hum Reprod; 1996 Jan; 11(1):68-9. PubMed ID: 8671159
[TBL] [Abstract][Full Text] [Related]
17. Severe ovarian hyperstimulation syndrome modifies early maternal serum beta-human chorionic gonadotropin kinetics, but obstetrical and neonatal outcomes are not impacted.
Choux C; Barberet J; Ginod P; Cottenet J; Bruno C; Benzénine E; Sagot P; Fauque P
Fertil Steril; 2017 Oct; 108(4):650-658.e2. PubMed ID: 28911926
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndrome.
Lainas GT; Lainas TG; Venetis CA; Sfontouris IA; Zorzovilis IZ; Alexopoulou E; Tarlatzis BC; Kolibianakis EM
Ultrasound Obstet Gynecol; 2018 Jan; 51(1):126-133. PubMed ID: 29105961
[TBL] [Abstract][Full Text] [Related]
19. Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadotrophin releasing hormone.
Weissman A; Barash A; Shapiro H; Casper RF
Hum Reprod; 1998 Dec; 13(12):3421-4. PubMed ID: 9886527
[TBL] [Abstract][Full Text] [Related]
20. Timed unilateral ovarian follicular aspiration prior to administration of human chorionic gonadotrophin for the prevention of severe ovarian hyperstimulation syndrome in in-vitro fertilization: a prospective randomized study.
Egbase PE; Makhseed M; Al Sharhan M; Grudzinskas JG
Hum Reprod; 1997 Dec; 12(12):2603-6. PubMed ID: 9455821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
